Intuitive Surgical, Inc. (ISRG) Income Statement Analysis

See more : Agri-tech (India) Limited (AGRITECH.NS) Income Statement Analysis – Financial Results

Complete financial analysis of Intuitive Surgical, Inc. (ISRG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Intuitive Surgical, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.

You may be interested

Siemens Aktiengesellschaft (SIA.BR) Income Statement Analysis – Financial Results
Hindalco Industries Limited (HINDALCO.BO) Income Statement Analysis – Financial Results
Stockwik Förvaltning AB (publ) (STWK.ST) Income Statement Analysis – Financial Results
Northern Dynasty Minerals Ltd. (NAK) Income Statement Analysis – Financial Results
Hasti Finance Limited (HASTIFIN.BO) Income Statement Analysis – Financial Results

Intuitive Surgical, Inc. (ISRG)

Industry: Medical - Instruments & Supplies

Sector: Healthcare

Website: https://www.intuitive.com

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998
Revenue	7.12B	6.22B	5.71B	4.36B	4.48B	3.72B	3.13B	2.70B	2.38B	2.13B	2.27B	2.18B	1.76B	1.41B	1.05B	874.92M	600.83M	372.68M	227.34M	138.80M	91.68M	72.02M	51.67M	26.62M	10.19M	0.00
Cost of Revenue	2.39B	2.03B	1.75B	1.50B	1.37B	1.12B	934.80M	814.30M	806.50M	717.90M	670.90M	608.50M	483.50M	383.00M	301.12M	254.14M	186.54M	124.85M	73.77M	50.81M	47.65M	34.58M	28.22M	13.28M	7.03M	0.00
Gross Profit	4.73B	4.20B	3.96B	2.86B	3.11B	2.60B	2.19B	1.89B	1.58B	1.41B	1.59B	1.57B	1.27B	1.03B	751.05M	620.78M	414.29M	247.84M	153.57M	87.99M	44.03M	37.44M	23.46M	13.35M	3.16M	0.00
Gross Profit Ratio	66.39%	67.44%	69.32%	65.65%	69.45%	69.92%	70.12%	69.89%	66.18%	66.32%	70.38%	72.07%	72.49%	72.89%	71.38%	70.95%	68.95%	66.50%	67.55%	63.39%	48.03%	51.98%	45.39%	50.12%	31.02%	0.00%
Research & Development	998.80M	879.00M	671.00M	595.10M	557.30M	418.10M	328.60M	239.60M	197.40M	178.00M	167.70M	170.00M	140.20M	116.00M	95.10M	79.37M	48.86M	29.78M	17.35M	17.81M	16.19M	16.79M	13.85M	11.73M	11.13M	23.21M
General & Administrative	0.00	0.00	0.00	0.00	0.00	986.60M	810.90M	705.30M	640.50M	691.00M	574.00M	522.20M	438.80M	358.80M	278.51M	230.57M	158.69M	110.70M	67.44M	48.99M	39.72M	40.86M	29.99M	19.14M	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	1.96B	1.74B	1.47B	1.22B	1.18B	986.60M	810.90M	705.30M	640.50M	691.00M	574.00M	522.20M	438.80M	358.80M	278.51M	230.57M	158.69M	110.70M	67.44M	48.99M	39.72M	40.86M	29.99M	19.14M	9.34M	7.57M
Other Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.75M	11.58M	7.57M
Operating Expenses	2.96B	2.62B	2.14B	1.81B	1.74B	1.40B	1.14B	944.90M	837.90M	869.00M	741.70M	692.20M	579.00M	474.80M	373.61M	309.94M	207.54M	140.48M	84.80M	66.81M	55.91M	57.66M	43.84M	35.62M	22.71M	30.77M
Cost & Expenses	5.36B	4.65B	3.89B	3.31B	3.10B	2.52B	2.07B	1.76B	1.64B	1.59B	741.70M	1.30B	1.06B	857.80M	674.73M	564.08M	394.09M	265.33M	158.57M	117.62M	103.56M	92.24M	72.06M	48.90M	29.74M	30.77M
Interest Income	192.10M	29.70M	69.30M	157.20M	116.80M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	14.90M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.00	29.70M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.80M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	421.80M	380.40M	317.00M	282.50M	199.70M	120.10M	95.00M	88.90M	89.50M	74.40M	67.30M	57.80M	46.50M	40.40M	34.58M	25.08M	13.03M	35.27M	6.73M	7.11M	10.63M	4.55M	4.71M	4.75M	2.24M	0.00
EBITDA	2.17B	1.58B	1.82B	1.05B	1.37B	1.32B	1.16B	1.05B	740.00M	619.20M	919.80M	935.90M	741.30M	595.60M	377.44M	335.92M	219.77M	107.36M	75.50M	21.18M	-1.25M	-15.67M	-15.67M	-17.53M	-17.31M	-30.77M
EBITDA Ratio	30.45%	25.35%	31.89%	24.09%	30.69%	32.21%	33.71%	34.95%	31.04%	25.56%	37.64%	40.30%	39.54%	39.29%	35.87%	38.39%	36.58%	38.27%	33.44%	20.21%	-1.79%	-21.70%	-30.41%	-65.42%	-169.80%	0.00%
Operating Income	1.77B	1.21B	1.82B	773.60M	1.37B	1.20B	1.05B	945.20M	740.00M	544.80M	852.50M	878.10M	694.80M	555.20M	377.44M	310.84M	206.74M	107.36M	68.77M	21.18M	-11.88M	-20.22M	-20.38M	-22.28M	-19.55M	-30.77M
Operating Income Ratio	24.80%	19.47%	31.89%	17.75%	30.69%	32.21%	33.71%	34.95%	31.04%	25.56%	37.64%	40.30%	39.54%	39.29%	35.87%	35.53%	34.41%	28.81%	30.25%	15.26%	-12.96%	-28.07%	-39.45%	-83.67%	-191.81%	0.00%
Total Other Income/Expenses	192.10M	29.70M	69.30M	157.20M	127.70M	80.10M	41.90M	35.60M	18.50M	4.20M	18.40M	15.80M	14.90M	17.10M	18.67M	24.37M	30.49M	12.78M	5.04M	3.02M	2.26M	1.80M	42.00K	-108.00K	0.00	0.00
Income Before Tax	1.96B	1.61B	1.89B	1.21B	1.50B	1.28B	1.10B	980.80M	758.50M	549.00M	870.90M	893.90M	709.70M	572.30M	396.11M	335.20M	237.23M	120.14M	73.81M	24.20M	-9.62M	-18.42M	-20.34M	-22.39M	0.00	0.00
Income Before Tax Ratio	27.50%	25.82%	33.10%	27.69%	33.54%	34.36%	35.04%	36.27%	31.81%	25.75%	38.45%	41.03%	40.39%	40.50%	37.65%	38.31%	39.48%	32.24%	32.47%	17.44%	-10.50%	-25.58%	-39.36%	-84.08%	0.00%	0.00%
Income Tax Expense	141.60M	262.40M	162.20M	140.20M	120.40M	154.50M	436.50M	244.90M	169.70M	130.20M	199.90M	237.30M	214.60M	190.50M	163.51M	130.89M	92.70M	48.09M	-20.33M	726.00K	-2.26M	-1.80M	-3.68M	-3.75M	-1.13M	29.44M
Net Income	1.80B	1.32B	1.70B	1.06B	1.38B	1.13B	660.00M	735.90M	588.80M	418.80M	671.00M	656.60M	495.10M	381.80M	232.61M	204.32M	144.54M	72.04M	94.13M	23.48M	-9.62M	-18.42M	-16.70M	-18.52M	-18.42M	-29.44M
Net Income Ratio	25.24%	21.25%	29.85%	24.33%	30.80%	30.29%	21.09%	27.21%	24.69%	19.65%	29.62%	30.14%	28.17%	27.02%	22.11%	23.35%	24.06%	19.33%	41.41%	16.91%	-10.50%	-25.58%	-32.32%	-69.57%	-180.68%	0.00%
EPS	5.12	3.72	4.79	3.02	3.98	3.31	1.97	2.13	1.76	1.26	1.86	1.83	1.40	1.08	0.67	0.58	0.42	0.22	0.30	0.08	-0.05	-0.11	-0.10	-0.17	-0.85	-1.81
EPS Diluted	5.03	3.65	4.66	2.94	3.85	3.16	1.89	2.08	1.73	1.23	1.86	1.78	1.37	1.05	0.66	0.57	0.41	0.21	0.28	0.07	-0.05	-0.11	-0.10	-0.17	-0.85	-1.81
Weighted Avg Shares Out	351.20M	355.70M	356.10M	351.00M	346.20M	341.10M	335.10M	344.70M	333.90M	332.10M	360.97M	358.20M	352.80M	352.80M	344.68M	349.89M	340.48M	330.63M	315.63M	303.24M	212.63M	164.06M	161.17M	107.08M	21.77M	16.29M
Weighted Avg Shares Out (Dil)	357.40M	362.00M	365.80M	360.90M	358.50M	356.40M	348.90M	353.70M	341.10M	339.30M	360.97M	369.90M	361.80M	362.70M	352.85M	359.49M	351.19M	342.84M	337.39M	314.78M	212.63M	164.06M	161.17M	107.08M	21.77M	16.29M

ISRG Stock To $5,000

October 26, 2024forbes.com

Change imagined: ISRG stock long term

Got $1,000? 2 Healthcare Stocks to Buy and Hold Forever.

October 25, 2024fool.com

These two stocks have moved in different directions this year, but that shouldn't mean much to long-term investors.

Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True?

October 23, 2024zacks.com

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

5 Monster Stocks to Hold for the Next 5 to 25 Years

October 23, 2024fool.com

Each has an impressive history of share price performance and great prospects for further growth.

Up 800% the Past Decade, Can the Momentum Continue for This Hot Stock?

October 22, 2024fool.com

Intuitive Surgical continues to be one of the market's hottest stocks.

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

October 21, 2024zacks.com

Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Oversold But Ready to Rally: 5 Stocks to Watch Now

October 21, 2024marketbeat.com

Buying oversold stocks is not a question of one man's trash being another's treasure. In many cases, it's simply the ability to look at specific fundamental or technical indicators as a way to identify stocks that are buying opportunities.

Intuitive Surgical Confirms Bullish Flag: 25% to 30% Upside Ahead

October 21, 2024marketbeat.com

Technical traders and technically-minded investors will rejoice after a look at the Intuitive Surgical NASDAQ: ISRG price chart. The market for this leading med-tech company has produced a strong rally since summer, rising $115 from the low to the high...

Compared to Estimates, Intuitive Surgical (ISRG) Q3 Earnings: A Look at Key Metrics

October 18, 2024zacks.com

While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street...